City Therapeutics Aims for $158M IPO as Iambic Targets $135M
City Therapeutics targets a $158M IPO while Iambic seeks $135M on Nasdaq, a combined $293M biotech test of the new-issue window, per Endpoints News.
Topic
Iambic Therapeutics
Topic
Iambic Therapeutics
Nvidia-Backed Iambic Therapeutics Files for Nasdaq IPO
Iambic Therapeutics, which raised $461.8 million from Nvidia and others, filed Monday for a Nasdaq IPO under ticker IAM to fund t…
Iambic Therapeutics Files for IPO as AI Drug Discovery Heats Up
AI drug discovery startup Iambic Therapeutics has filed for an initial public offering, Yahoo Finance reports, testing investor a…